Boston Scientific Names Joseph Fitzgerald as COO
MT newswire2026/10/07 10:3306:33 AM EDT, 10/07/2026 (MT Newswires) -- Boston Scientific (BSX) said Wednesday it appointed Joseph Fitzgerald as executive vice president and chief operating officer, effective Jan. 1, 2027. The company said Fitzgerald will oversee its global operations, business units and regions. Boston Scientific will also reorganize into three reporting segments, consisting of Interventional Therapies, Rhythm Solutions and MedSurg, it added. Lance Bates will lead Interventional Therapies, Nick Spadea-Anello will head Rhythm Solutions, and Stephen Morse will lead MedSurg and Asia Pacific, the company said, adding that all three will report to Fitzgerald. Fitzgerald currently serves as executive vice president and group president of Cardiovascular, Boston Scientific said.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Euro: Recovery holds as currency softens – BNY
Star Bulk director Koert Erhardt disposes of USD 182,340 in common shares
Star Bulk director Koert Erhardt sold 6,000 common shares on Oct. 5, 2026 at USD 30.39 each. Beneficial ownership fell to 10,080 common shares following the sale. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Star Bulk Carriers Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001333848-26-000005), on October 07, 2026, and is solely responsible for the information contained therein.
Vystar targets commercial launch of R3ALM platform as modules move into production
Vystar mapped a commercial rollout for the R3ALM Ecosystem as it moves from testing to live deployment of remaining modules. The platform is positioned as a 22-module financial and commerce ecosystem aimed at connecting capital formation, tokenized assets, and decision tools. Near-term execution centers on tokenization and digital commerce projects in collectibles, entertainment, and financial services to validate the model. The strategy targets diversified revenue through project economics, including ownership stakes, participation in digital assets or currencies, and revenue sharing. Further updates are planned as projects advance and additional modules enter production. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vystar Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610070958PRIMZONEFULLFEED9841416) on October 07, 2026, and is solely responsible for the information contained therein.
US Stock Market Fluctuation | Webull (BULL.US) plunges nearly 20%; app download volume has exceeded 50 million times
On Wednesday, Webull (BULL.US) plunged nearly 20%, closing at $5.83.
Crypto prices
More
